Eli Lilly (LLY) reported mostly worse-than-expected fourth-quarter results Thursday, but the drugmaker's adjusted profit came in above estimates. Eli Lilly reported net income of $4.41 billion, or $4.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Ushered behind a curtain, my heart skipped a beat when I saw the four wedding gowns hanging on the rail. Each one was suited to my kitsch dream: there was lace, sparkle, satin and feathers to spare.